# Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension

> **NCT00984932** · PHASE3 · COMPLETED · sponsor: **University of Alexandria** · enrollment: 40 (actual)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00984932
- **Lead sponsor:** University of Alexandria
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2009-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00984932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00984932, "Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00984932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*